• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性医护环境下内分泌疾病相关夜尿症的评估与治疗:系统评价与名义群体技术共识。

Assessment and Treatment of Nocturia in Endocrine Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus.

机构信息

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Endocrinology and Diabetes Department, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

出版信息

Eur Urol Focus. 2022 Jan;8(1):52-59. doi: 10.1016/j.euf.2021.12.008. Epub 2022 Jan 5.

DOI:10.1016/j.euf.2021.12.008
PMID:34996740
Abstract

CONTEXT

Salt and water homeostasis is regulated hormonally, so polyuria can result from endocrine disease directly or via secondary effects. These mechanisms are not consistently considered in primary care management of nocturia.

OBJECTIVE

To conduct a systematic review (SR) of nocturia in endocrine disease and reach expert consensus for primary care management.

EVIDENCE ACQUISITION

Four databases were searched from January 2000 to April 2020. A total of 4382 titles and abstracts were screened, 36 studies underwent full-text screening, and 14 studies were included in the analysis. Expert and public consensus was achieved using the nominal group technique (NGT).

EVIDENCE SYNTHESIS

Twelve studies focused on mechanisms of nocturia, while two evaluated treatment options; none of the studies took place in a primary care setting. NGT consensus identified key clinical evaluation themes, including the presence of thirst, a medical background of diabetes mellitus or insipidus, thyroid disease, oestrogen status, medications (fluid loss or xerostomia), and general examination including body mass index. Proposed investigations include a bladder diary, renal and thyroid function, calcium, and glycated haemoglobin. Morning urine osmolarity should be examined in the context of polyuria of >2.5 l/24 h persisting despite fluid advice, with urine concentration >600 mOsm/l after fluid restriction excluding diabetes insipidus. Treatment should involve education, including adjustment of lifestyle and medication where possible. Any underlying endocrine disorder should be managed according to local guidance. Referral to endocrinology is needed if there is hyperthyroidism, hyperparathyroidism, or morning urine osmolarity <600 mOsm/l after overnight fluid avoidance.

CONCLUSIONS

Endocrine disease can result in nocturia via varied salt and water regulation pathways. The aim of management is to identify and treat causative factors, but secondary effects can restrict improvements in nocturia.

PATIENT SUMMARY

People with altered hormone function can suffer from severe sleep disturbance because of a need to pass urine caused by problems in controlling water and salt levels. An expert panel recommended the best ways to assess and treat these problems on the basis of the rather small amount of up-to-date published research available.

摘要

背景

盐和水的动态平衡受激素调节,因此多尿可由内分泌疾病直接引起,也可通过继发效应引起。这些机制在夜间多尿的初级保健管理中并未得到一致考虑。

目的

对内分泌疾病中的夜间多尿进行系统评价(SR),并就初级保健管理达成专家共识。

证据获取

从 2000 年 1 月至 2020 年 4 月,四个数据库进行了检索。共筛选出 4382 篇标题和摘要,对 36 篇全文进行了筛选,最终纳入 14 项研究进行分析。使用名义群体技术(NGT)达成专家和公众共识。

证据综合

12 项研究侧重于夜间多尿的发生机制,而 2 项研究评估了治疗选择;没有一项研究在初级保健环境中进行。NGT 共识确定了关键的临床评估主题,包括口渴的存在、糖尿病或尿崩症的医学背景、甲状腺疾病、雌激素状态、药物(液体流失或口干)以及包括体重指数在内的一般检查。建议的检查包括膀胱日记、肾功能和甲状腺功能、钙和糖化血红蛋白。如果在液体建议后持续出现 >2.5 l/24 h 的多尿,且在限制液体后尿液浓缩度 >600 mOsm/l,则应检查晨尿渗透压,排除尿崩症。治疗应包括教育,包括尽可能调整生活方式和药物。应根据当地指南治疗任何潜在的内分泌疾病。如果存在甲状腺功能亢进症、甲状旁腺功能亢进症或在夜间避免饮水后晨尿渗透压 <600 mOsm/l,则应将患者转至内分泌科。

结论

内分泌疾病可通过多种盐和水调节途径引起夜间多尿。管理的目的是识别和治疗病因,但继发效应会限制夜间多尿的改善。

患者总结

由于控制水盐水平的问题导致需要排尿,激素功能改变的人可能会遭受严重的睡眠障碍。一个专家小组根据现有最新研究数量较少的情况,就评估和治疗这些问题的最佳方法提出了建议。

相似文献

1
Assessment and Treatment of Nocturia in Endocrine Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus.原发性医护环境下内分泌疾病相关夜尿症的评估与治疗:系统评价与名义群体技术共识。
Eur Urol Focus. 2022 Jan;8(1):52-59. doi: 10.1016/j.euf.2021.12.008. Epub 2022 Jan 5.
2
Nocturia and Chronic Kidney Disease: Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and Treatment.夜尿症和慢性肾脏病:初级保健评估和治疗的系统评价和名义群体技术共识。
Eur Urol Focus. 2022 Jan;8(1):18-25. doi: 10.1016/j.euf.2021.12.010. Epub 2022 Jan 12.
3
Implications of Cardiovascular Disease for Assessment and Treatment of Nocturia in Primary Care: Systematic Review and Nominal Group Technique Consensus.心血管疾病对初级保健中夜尿症评估和治疗的影响:系统评价和名义群体技术共识。
Eur Urol Focus. 2022 Jan;8(1):26-32. doi: 10.1016/j.euf.2021.12.014. Epub 2022 Jan 12.
4
Assessment and Treatment of Nocturia in Neurological Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus.在初级保健环境中对神经疾病患者夜尿症的评估和治疗:系统评价和名义群体技术共识。
Eur Urol Focus. 2022 Jan;8(1):33-41. doi: 10.1016/j.euf.2021.12.012. Epub 2022 Jan 12.
5
Association of Sleep Disorders with Nocturia: A Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and Treatment.睡眠障碍与夜尿症的关联:初级保健评估和治疗的系统评价和名义群体技术共识。
Eur Urol Focus. 2022 Jan;8(1):42-51. doi: 10.1016/j.euf.2021.12.011. Epub 2022 Jan 10.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
The use of virtual nominal groups in healthcare research: An extended scoping review.在医疗保健研究中使用虚拟名词短语:扩展范围综述。
PLoS One. 2024 Jun 12;19(6):e0302437. doi: 10.1371/journal.pone.0302437. eCollection 2024.